The NICE-PAD II Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT07782671
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 250 participants
- Registry
-
NCT07782671
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07782671. Randomized; quadruple masking; primary purpose treatment. Start 2027-02 (anticipated); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The NICE-PAD II Trial
- Acronym
- NICE
- Condition
- Peripheral Artery Disease (PAD)
- Intervention (Drug)
- Nicotinamide Riboside (NR)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Northwestern University
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct07782671- Content hash
43604581d9354a08644447bc203d8e6d5dc9258b3aadf4c789e06cbc53b6bb60